C

Cytokinetics

Develops small-molecule therapies for muscle function

Medical Director - US Medical Affairs, Hypertrophic Cardiomyopathy

Biology & BiotechConfirmed live in the last 24 hours
Full-time$276.1k - $322.1k

About the Job

Requirements

  • MD, DO, or PharmD and prior pharmaceutical industry and Medical Affairs Medical Director experience, including 3–5 years of Medical Affairs experience.
  • Cardiovascular training and clinical experience are strongly preferred.
  • Knowledge of Medical Affairs strategy, including evidence generation, scientific communications, and external engagement, is strongly preferred.
  • Ability to critically evaluate and interpret clinical trial data, peer-reviewed literature, treatment guidelines, and real-world evidence.
  • Ability to work independently and as a member of an integrated, interdisciplinary team in carrying out assigned responsibilities.
  • Ability to translate complex scientific information into clear, accurate, and actionable medical guidance.
  • Project management skills, including managing multiple priorities, budgets, vendors, timelines, and deliverables.
  • Working knowledge of congress strategy, advisory boards, medical education, and scientific communications.
  • Strong oral and written articulation and presentation skills, including executive communication and communication with people at varying professional levels.
  • High level of scientific integrity, sound medical judgment, professionalism, and commitment to patient benefit.
  • Proficiency with Microsoft Office.
  • Ability to travel approximately 30% of the time.

Responsibilities

  • Support the ongoing development of aficamten.
  • Assist in developing and executing medical strategy, including the US Plan of Action, aligned with organizational, therapeutic area, and product objectives.
  • Serve as a medical and scientific expert for the assigned therapeutic area.
  • Educate healthcare professionals regarding aficamten's clinical profile and its place in hypertrophic cardiomyopathy therapy.
  • Provide medical leadership throughout aficamten development, launch readiness, and lifecycle management.
  • Execute medical launch activities.
  • Provide medical input into cross-functional, brand, evidence generation, market access, and lifecycle management plans.
  • Provide medical expertise and input for REMS activities.
  • Partner with Clinical Development, Commercial, Regulatory, Safety, HEOR, Market Access, and Legal/Compliance on strategic workstreams and deliverables, including scientific congress strategy and planning, advisory boards, field force training, review of medical information standard response letters, health economics and epidemiology analyses, and marketing and policy projects.
  • Collaborate with regional and global colleagues to ensure aligned strategy while addressing local stakeholder needs.
  • Participate in cross-functional Medical and Commercial teams to inform aficamten brand strategies and tactics.
  • Provide input into hypertrophic cardiomyopathy medical education, grant, and sponsorship review, and review metrics evaluating the reach, quality, and impact of medical education initiatives.
  • Manage medical programs, vendors, timelines, budgets, contracts, and performance measures.
  • Provide clinical and scientific support in responding to healthcare professional inquiries.
  • Support Medical Affairs review of medical and promotional scientific materials related to hypertrophic cardiomyopathy and aficamten via MLR.
  • Participate in developing the integrated evidence plan strategy, including identifying evidence gaps, and contribute to evidence generation strategy, including real-world evidence and investigator-sponsored research.
  • Collaborate with Field Medical Affairs to establish scientific priorities, training plans, and insight and stakeholder engagement strategy.
  • Analyze field medical insights to inform medical, evidence generation, and educational strategy.
  • Collaborate with US Field Medical Affairs to support field material development and address healthcare professional inquiries.
  • Assist with Field Medical education on emerging aficamten data and hypertrophic cardiomyopathy topics.
  • Build and maintain an active US key opinion leader hypertrophic cardiomyopathy expert network.
  • Identify and interact effectively with hypertrophic cardiomyopathy external experts to engage in scientific exchange and meet the needs of patients and the medical community.

Desired Qualifications

  • Prior experience with product approvals, launch, and peri-launch activities is highly desirable.
  • Background in academic medicine, clinical research, and familiarity with biostatistics and epidemiology are highly desirable.
  • Prior experience managing vendors, budgets, and strategic timelines is a plus.
  • Experience developing medical plans and aligning medical objectives with broader product and organizational strategy is a plus.
  • Familiarity with OPDP, PhRMA code, and key pharmaceutical industry regulations is a plus.

About the Company

Cytokinetics

Develops small-molecule therapies for muscle function

Cytokinetics develops and commercializes small molecule drugs aimed at improving muscle function for cardiovascular and neuromuscular diseases. Its products are designed to either enhance or adjust muscle contraction, with a pipeline that includes compounds like omecamtiv mecarbil, reldesemtiv, CK-274, AMG 594, and CK-601, currently in various stages of clinical trials. The company advances therapies through partnerships, licensing, and potential sales of approved medicines, and relies on extensive clinical testing to demonstrate effectiveness and safety. What sets Cytokinetics apart is its focused approach on muscle function modulators (activators and inhibitors) for both heart and skeletal muscle diseases, targeting conditions such as heart failure, hypertrophic cardiomyopathy, ALS, and SMA. Its goal is to bring medicines to patients to improve muscle performance and daily function, addressing unmet medical needs in these diseases.

Company size
501-1,000
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Cytokinetics

See more jobs